The Alaska Department of Health and Social Services recorded the state’s second case of monkeypox last Wednesday, according to state epidemiologist Dr. Joe McLaughlin.
The new case involves an adult male who began experiencing symptoms within the last week. Both cases are in Anchorage and McLaughlin said neither has required hospitalization.
The case count is expected to rise “steadily,” said McLaughlin.
Monkeypox spreads through prolonged contact with someone who carries the virus, and the majority of cases are from sexual contact.
“It’s not spread through casual conversations or by walking past somebody in a grocery store,” McLaughlin said.
So far, McLaughlin said 16 Alaskans have been vaccinated against monkeypox. The state is currently prioritizing vaccines for two tiers of at-risk individuals. Tier 1 includes people with a known exposure to someone who tested positive for monkeypox. Tier 2 includes people who may be at high risk of exposure.
Alaska has about 330 doses of vaccine, according to McLaughlin. The state will have an opportunity to order more from the federal government in about two weeks. Some states with higher case counts already have long waitlists for the vaccine.
“There are going to be a lot of people who meet the criteria for Tier 2,” McLaughlin said. “The sooner people who meet those criteria for Tier 1 or Tier 2 reach out to their health care provider, the sooner they’ll get a vaccine.”
McLaughlin recommended contacting your local public health center to request a vaccine.
The state currently has four courses of treatment for monkeypox, which are being reserved for severe cases. McLaughlin said. Alaska has quick access to more treatment as needed through the Federal Strategic National Stockpile.
